Michael Lamson

1.1k total citations
25 papers, 842 citations indexed

About

Michael Lamson is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Virology. According to data from OpenAlex, Michael Lamson has authored 25 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Virology. Recurrent topics in Michael Lamson's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (6 papers) and Pain Management and Opioid Use (4 papers). Michael Lamson is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (6 papers) and Pain Management and Opioid Use (4 papers). Michael Lamson collaborates with scholars based in United States, Israel and Germany. Michael Lamson's co-authors include Thomas R. MacGregor, John P. Sabo, Joseph Pav, James J. Keirns, Patrick Robinson, Katherine Luzuriaga, Susannah Cort, Susan E. Hattox, Yvonne J. Bryson and Paul Riska and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Lamson

24 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Lamson United States 12 579 398 140 132 114 25 842
Laura Dickinson United Kingdom 19 662 1.1× 374 0.9× 191 1.4× 163 1.2× 155 1.4× 68 999
Concepta Merry Ireland 18 780 1.3× 411 1.0× 187 1.3× 216 1.6× 126 1.1× 29 1.1k
SH Khoo United Kingdom 15 614 1.1× 275 0.7× 166 1.2× 200 1.5× 123 1.1× 40 843
Robin DiFrancesco United States 18 538 0.9× 298 0.7× 204 1.5× 137 1.0× 117 1.0× 53 968
Agnes I. Veldkamp Netherlands 17 697 1.2× 510 1.3× 140 1.0× 185 1.4× 118 1.0× 27 943
Kristel M. L. Crommentuyn Netherlands 16 661 1.1× 334 0.8× 246 1.8× 154 1.2× 105 0.9× 21 864
Gregory E. Chittick United States 15 484 0.8× 287 0.7× 116 0.8× 198 1.5× 90 0.8× 18 798
Monique M. R. de Maat Netherlands 10 431 0.7× 229 0.6× 121 0.9× 118 0.9× 100 0.9× 15 606
Bregt S Kappelhoff Netherlands 11 530 0.9× 349 0.9× 100 0.7× 124 0.9× 96 0.8× 21 693
Helen Reynolds United Kingdom 15 397 0.7× 184 0.5× 199 1.4× 134 1.0× 117 1.0× 40 661

Countries citing papers authored by Michael Lamson

Since Specialization
Citations

This map shows the geographic impact of Michael Lamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lamson more than expected).

Fields of papers citing papers by Michael Lamson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lamson. The network helps show where Michael Lamson may publish in the future.

Co-authorship network of co-authors of Michael Lamson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lamson. A scholar is included among the top collaborators of Michael Lamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lamson. Michael Lamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dretchen, Kenneth L., et al.. (2023). A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector. SHILAP Revista de lepidopterología. 3(2). 100200–100200. 7 indexed citations
2.
Perlstein, Itay, Roberto Goméni, Michael Lamson, et al.. (2022). Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone. Clinical Pharmacology in Drug Development. 11(7). 865–877. 8 indexed citations
3.
Белогурова, М. Б., Miklós Garami, Monika Csóka, et al.. (2016). A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma. Cancer Chemotherapy and Pharmacology. 79(1). 155–164. 4 indexed citations
4.
5.
6.
Gandelman, Kuan, et al.. (2014). Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO‐02, an extended release formulation of oxycodone with sequestered naltrexone. Clinical Pharmacology in Drug Development. 4(5). 370–376. 2 indexed citations
7.
Goli, Veeraindar, Lynn R. Webster, Michael Lamson, et al.. (2012). Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide. Harm Reduction Journal. 9(1). 13–13. 5 indexed citations
8.
Lamson, Michael, et al.. (2011). Pharmacokinetics of Diazepam Administered Intramuscularly by Autoinjector versus Rectal Gel in Healthy Subjects. Clinical Drug Investigation. 31(8). 585–597. 29 indexed citations
9.
Mills, Kenneth C., Susan E. Spruill, Jason Walker, & Michael Lamson. (2009). A Clinical Trial Demonstration of a Web-Based Test for Alcohol and Drug Effects. Journal of Studies on Alcohol and Drugs. 70(2). 308–313. 3 indexed citations
10.
Barrett, Richard J., Michael Lamson, James R. Johnson, & William Smith. (2005). Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers. Journal of Nuclear Cardiology. 12(2). 166–171. 14 indexed citations
11.
Mildvan, Donna, et al.. (2002). Pharmacokinetic Interaction Between Nevirapine and Ethinyl Estradiol/Norethindrone When Administered Concurrently to HIV-Infected Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(5). 471–477. 64 indexed citations
12.
Lamson, Michael, et al.. (2002). Pharmacokinetics of lovastatin extended‐release dosage form (Lovastatin XL) in healthy volunteers. Biopharmaceutics & Drug Disposition. 23(4). 143–149. 9 indexed citations
13.
Sabo, John P., Michael Lamson, G Leitz, Chan‐Loi Yong, & Thomas R. MacGregor. (2000). Pharmacokinetics of nevirapine and lamivudine in patients with HIV-1 infection. PubMed. 2(1). 1–8. 49 indexed citations
14.
Lamson, Michael, John P. Sabo, Thomas R. MacGregor, et al.. (1999). Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers. Biopharmaceutics & Drug Disposition. 20(6). 285–291. 53 indexed citations
15.
Murphy, Robert L., Jean‐Pierre Sommadossi, Michael Lamson, et al.. (1999). Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 179(5). 1116–1123. 99 indexed citations
16.
Riska, Paul, Michael Lamson, Thomas R. MacGregor, et al.. (1999). Disposition and Biotransformation of the Antiretroviral Drug Nevirapine in Humans. Drug Metabolism and Disposition. 27(8). 895–901. 174 indexed citations
17.
Luzuriaga, Katherine, Yvonne J. Bryson, Paul Krogstad, et al.. (1997). Combination Treatment with Zidovudine, Didanosine, and Nevirapine in Infants with Human Immunodeficiency Virus Type 1 Infection. New England Journal of Medicine. 336(19). 1343–1349. 149 indexed citations
18.
Luzuriaga, Katherine, Yvonne J. Bryson, George McSherry, et al.. (1996). Pharmacokinetics, Safety, and Activity of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Children. The Journal of Infectious Diseases. 174(4). 713–721. 58 indexed citations
19.
Lamson, Michael, et al.. (1994). Effects of hexagonal phase induction by dolichol on phospholipid membrane permeability and morphology. International Journal of Pharmaceutics. 105(3). 259–272. 15 indexed citations
20.
Lamson, Michael, et al.. (1986). Prediction of acetaminophren level from clinical history of overdose using a pharmacokinetic model. Annals of Emergency Medicine. 15(11). 1314–1319. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Dickinson Breakdown of academic impact, for papers by Concepta Merry Breakdown of academic impact, for papers by SH Khoo Breakdown of academic impact, for papers by Robin DiFrancesco Breakdown of academic impact, for papers by Agnes I. Veldkamp Breakdown of academic impact, for papers by Kristel M. L. Crommentuyn Breakdown of academic impact, for papers by Gregory E. Chittick Breakdown of academic impact, for papers by Monique M. R. de Maat Breakdown of academic impact, for papers by Bregt S Kappelhoff Breakdown of academic impact, for papers by Helen Reynolds
Rankless by CCL
2026